53 related articles for article (PubMed ID: 2908354)
1. Immune mechanisms of tissue destruction in vivo.
Singer A; Rosenberg AS
Princess Takamatsu Symp; 1988; 19():209-14. PubMed ID: 2908354
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the effector mechanism of skin allograft rejection is antigen-specific.
Rosenberg AS; Singer A
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7739-42. PubMed ID: 2459716
[TBL] [Abstract][Full Text] [Related]
3. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
Rosenberg AS; Katz SI; Singer A
J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
[TBL] [Abstract][Full Text] [Related]
4. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC.
Rosenberg AS; Mizuochi T; Singer A
Nature; 1986 Aug 28-Sep 3; 322(6082):829-31. PubMed ID: 3528862
[TBL] [Abstract][Full Text] [Related]
5. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
7. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
[TBL] [Abstract][Full Text] [Related]
8. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
[TBL] [Abstract][Full Text] [Related]
9. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
10. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
11. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
Felix NJ; de Serres S; Meyer AA; Ting JP
J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
[TBL] [Abstract][Full Text] [Related]
13. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
[TBL] [Abstract][Full Text] [Related]
14. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
16. Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
Bemelman F; Yong SL; Tissingh R; Schellekens P; ten Berge I
Transpl Int; 2005 Apr; 18(4):423-8. PubMed ID: 15773962
[TBL] [Abstract][Full Text] [Related]
17. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
[TBL] [Abstract][Full Text] [Related]
19. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
20. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
Williams IR; Perry LL
J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
